HIF1A and ischemia: Based on our preliminary experiments, 5 μM 2-MeOE2-treated cardiomyocytes and 2 μM 2-MeOE2-treated isolated hearts were used to investigate the role of the HIF-1α pathway in mediating the protective effects of post-ischemia treatment with Ast IV against myocardial IRI.